Skip To Main Content
Kaahini Jain on Muck Rack

Kaahini Jain

As seen in: Harvard University, MDPI, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kaahini

Contact Kaahini, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Personalizing the Complete Blood Count Test Could Improve Patient Care

|
By Kaahini Jain
| Harvard University
In a retrospective analysis of more than 12,000 adults who received multiple CBC tests across 20 years, the researchers showed that these reference intervals are far from widely generalizable. It’s known that people’s CBC ranges can shift due to factors such as genetics, disease history, and age. However, the new study suggests that individual patients have a set point — a stable value around which their CBC measures fluctuate.
Open in Who Shared Issue with article?

The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice

|
By Kelly K. Wingfield, Teodora Misic, Kaahini Jain, Carly S McDermott
| BioRxiv
Abstract Rationale: Opioid use during pregnancy can lead to negative infant health outcomes, including neonatal opioid withdrawal syndrome (NOWS). NOWS comprises gastrointestinal, autonomic nervous system, and neurological dysfunction that manifest during spontaneous withdrawal. Variability in NOWS severity necessitates a more individualized treatment approach.
Open in Who Shared Issue with article?

Spectrotemporal profiling of ultrasonic vocalizations during neonatal opioid withdrawal reveals a kappa opioid receptor component in female mice

|
By Kelly K. Wingfield, Kaahini Jain, Teodora Misic, Carly S McDermott
| BioRxiv
Abstract Opioid use during pregnancy can lead to negative infant health outcomes, including neonatal opioid withdrawal syndrome(NOWS). NOWS comprises gastrointestinal, autonomic nervous system, and neurological dysfunction that manifest during spontaneous withdrawal. Current treatments involve non-pharmacological and pharmacological interventions, however, there is no one standardized approach, in part because of variability in NOWS severity.
Open in Who Shared Issue with article?
See all 5 articles